Local Concentration of Folate Binding Protein GP38 in Sections of Human Ovarian Carcinoma by in Vitro Quantitative Autoradiography

Journal of Nuclear Medicine

Volumn 37, Issue 4-6, 1996, Pages 665-672

  Li, Pei Yong ^b   Del Vecchio, Silvana ^a   Fonti, Rosa ^b   Carriero, Maria V ^b   Potena, Maria I ^b   Botti, Gerardo ^b   Miotti, Silvia ^b   Lastoria, Secondo ^b   Menard, Sylvie ^b   Colnaghi, Maria I ^b   Salvatore, Marco ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NONE

Author keywords

Folate binding protein; Folate receptor; GP38; MOv18; Ovarian carcinoma

Indexed keywords

CARRIER PROTEIN; CELL SURFACE RECEPTOR; DIAGNOSTIC AGENT; FOLATE BINDING PROTEIN; FOLATE-BINDING PROTEIN; MONOCLONAL ANTIBODY; RADIOACTIVE IODINE;

ADULT; AGED; ARTICLE; AUTORADIOGRAPHY; CELL CULTURE; CHEMISTRY; COLLOID CARCINOMA; CYSTADENOMA; ENZYME IMMUNOASSAY; FEMALE; HUMAN; METHODOLOGY; MIDDLE AGED; OVARY; OVARY TUMOR;

ADENOCARCINOMA, MUCINOUS; ADULT; AGED; ANTIBODIES, MONOCLONAL; AUTORADIOGRAPHY; CARRIER PROTEINS; CYSTADENOMA, SEROUS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; IODINE RADIOISOTOPES; MIDDLE AGED; OVARIAN NEOPLASMS; OVARY; RECEPTORS, CELL SURFACE; TUMOR CELLS, CULTURED;

EID: 0030117317     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Antony AC. The biological chemistry of folate receptors. Blood 1992;79:2807-2820.
2. Kamen BA, Wang MT, Streckfuss AJ, Peryea X, Anderson RGW. Delivery of folates to the cytoplasm of MA104 cells is mediated by a surface membrane receptor that recycles. J Biol Chem 1988;263:13602-13609.
3. Luhrs CA, Slomiany BL. A human membrane-associated folate binding protein is anchored by a glycosylphosphatidylinositol tail. J Biol Chem 1989;264:21446-21449.
4. Weitman SD, Lark RH, Coney LR, et al. Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. Cancer Res 1992;52:3396-3401.
5. Kamen BA, Capdevila A. Receptor-mediated folate accumulation is regulated by the cellular folate content. Proc Natl Acad Sci USA 1986;83:5983-5987.
6. Kane MA, Elwood PC, Portillo RM, et al. Influence of immunoreactive folate-binding proteins of extracellular folate concentration on cultured human cells. J Clin Invest 1988;81:1398-1406.
7. Miotti S, Canevari S, Menard S, et al. Characterization of human ovarian carcinoma-associated antigens defined by novel monoclonal antibodies with tumor-restricted specificity. Int J Cancer 1987;39:297-303.
8. Coney LR, Tomassetti A, Carayannopoulos L, et al. Cloning of a tumor-associated antigen: MOv18 and MOv19 antibodies recognize a folate binding protein. Cancer Res 1991;51:6125-6132.
9. Campbell IG, Jones TA, Foulkes WD, Trowsdale J Folate binding protein is a marker for ovarian carcinoma. Cancer Res 1991;51:5329-5338.
10. Veggian R, Fasolato S, Menard S, et al. Immunohistochemical reactivity of a monoclonal antibody prepared against human ovarian carcinoma on normal and pathological female genital tissues. Tumori 1989;75:510-513
11. Mamovani LT, Miotti S, Menard S. et al. Folate binding protein distribution in normal tissues and biological fluids from ovarian carcinoma patients as detected by the monoclonal antibodies MOv18 and MOv19. Eur J Cancer 1994;30:363-369.
12. Weitman SD, Weinberg AG, Coney LR, Zurawski VR, Jennings DS, Kamen BA. Cellular localization of the folate receptor: potential role in drug toxicity and folate homeostasis. Cancer Res 1992;52:6708-6711.
13. Crippa F, Buraggi GL, Di Re E, et al. Radioimmunoscintigraphy of ovarian cancer with the MOv18 monoclonal antibody. Eur J Cancer 1991;27:724-729.
14. Molthoff CJM, Buist MR, Kenemans P, Pinedo HM, Boven E. Experimental and clinical analysis of the characteristics of a chimeric monoclonal antibody, MOv18, reactive with an ovarian cancer-associated antigen. J Nucl Med 1992;33:2000-2005.
15. 2 fragments in ovarian carcinoma patients. Cancer Res 1993;53:5413-5418.
16. 2 antibody prolong host survival in a murine xenograft model. Cancer Res 1991;51:5716-5721.
17. Bolhuis RLH, Lamers CHJ, Goey SH, et al. Adoptive immunotherapy of ovarian carcinoma with BS-MAb-targeted lymphocytes: a multicenter study Int J Cancer 1992;7(suppl):78-81.
18. Jansen G, Schornagel JH, Westerhof GR, Rijksen G, Newell DR, Jackman AL. Multiple membrane transport systems for the uptake of folate based thymidylate synthase inhibitors. Cancer Res 1990;50:7544-7548.
19. Westerhof GR, Jansen G, van Emmerik N, et al. Membrane transport of natural folates and antifolate compounds in murine L1210 leukemia cells, role of carrier- and receptor-mediated transport systems. Cancer Res 1991;51:5507-5513.
20. 10-propargyl-5,8-dideazafolic acid (CB3717). Natl Cancer Inst Monogr 1987;5:213-218.
21. 10-propargyl-5,8-dideazafolic acid (CB3717) in advanced breast cancer. Eur J Cancer Clin Oncol 1988;24:733-736
22. 10-propargyl-5,8-dideazafolate (ICI 198583), an inhibitor of thymidylate synthase. In: Curtius HC, Gishla S, Blau N, eds. Chemistry and biology of pieridines. Berlin: Walter de Gruyter & Co.; 1989:1023-1026.
23. Young AB, Frey KA, Agranoff BW. Receptor assay: in vitro and in vivo In Phelps M, Mazziotta J, Schelbert H, eds. Positron emission tomography and autoradiography: principles and applications for the brain and heart. New York: Raven Press; 1986:73-111.
24. Del Vecchio S, Reynolds JC, Blasberg RG, et al. Measurement of local Mr 97000 and 250000 protein antigen concentration in sections of human melanoma tumor using in vitro quantitative autoradiography. Cancer Res 1988;48:5475-5481.
25. Fraker PJ, Speck JC. Protein and cell membrane iodinations with a sparingly soluble chloramide 1,3,4,6 tetrachloro-3 alpha, 6 alpha-diphenylglycouril. Biochim Biophys Res Commun 1978;80:49-857.
26. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
27. Lindmo T, Boven E, Cuttitta F, Fedorko J, Bunn PA. Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess. J Immunol Methods 1984;72:77-89.
28. Del Vecchio S, Stoppelli MP, Carriero MV, et al. Human urokinase receptor concentration in malignant and benign breast tumors by in vitro quantitative autoradiography: comparison with urokinase levels. Cancer Res 1993;53:3198-3206.
29. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577-580.
30. Silva CM, Tully DB, Petch LA, Jewell MC, Cidlowski JA. Application of a protein-blotting procedure to the study of human glucocorticoid receptor interactions with DNA. Proc Natl Acad Sci USA 1987;84:1744-1748.
31. Sands H, Jones PL, Shah SA, Palme D, Vessella RL, Gallagher BM. Correlation of vascular permeability and blood flow with monoclonal antibody uptake by human Clouser and renal cell xenografts. Cancer Res 1988;48:188-193.
32. 1311-9.2.27 monoclonal antibody in human malignant melanoma. Cancer Res 1989;49:2783-2789.
33. Sung C, Youle RJ, Dedrick RL. Pharmacokinetic analysis of immunotoxin uptake in solid tumors. role of plasma kinetics, capillary permeability, and binding. Cancer Res 1990;50:7382-7392.
34. Juweid M, Neumann R, Paik C, et al. Micropharmacology of monoclonal antibodies in solid tumors: direct experimental evidence for a binding site barrier. Cancer Res 1992;52:5144-5153.
35. Shockley TR, Lin K, Sung C, et al. A quantitative analysis of tumor specific monoclonal antibody uptake by human melanoma xenografts: effects of antibody immunological properties and tumor antigen expression levels. Cancer Res 1992,52: 357-366.
36. Ross JF, Chaudhuri PK, Ratnam M. Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Cancer 1994;73:2432-2443.
37. Page TS, Owen WC, Price K, Elwood PC. Expression of the human placental folate receptor transcripts is regulated in human tissues. J Mol Biol 1993;229:1175-1183.
38. Shen F, Ross JF, Wang X, Ratnam M. Identification of a novel folate receptor, a truncated receptor, and receptor type β in hematopoietic cells: cDNA cloning, expression, immunoreactivity, and tissue specificity. Biochemistry 1994;33:1209-1215.
39. Sadasivan E, da Costa M, Rothenberg SP, Brink L. Purification, properties, and immunological characterization of folate-binding proteins from human leukemia cells. Biochim Biophys Acta 1987,925:36-47.